StockWatch
·

Avalo Therapeutics, Inc.

Ticker: 1534120

P/L Snapshot

Q3 FY24 · consolidated

vs Q3 FY24·vs Q3 FY23
Revenue
0.25
+0.0%+4.2%
Expenditure
13.11
+0.0%+228.6%
Net Profit
23.04
+0.0%+540.5%
OPM %
-100.00%

Shareholding

Pattern breakdown

P/L Trends

(in millions)

RevenueExpenditureNet Profit
-17.31-6.145.0216.1927.36Q2 FY22Q3 FY22Q1 FY23Q1 FY23Q1 FY23Q2 FY23Q2 FY23Q3 FY23Q3 FY24Q3 FY24
Price Chart
Latest News